Vir Biotechnology VIR
NASDAQ VIR
$10.57 -0.17 (-1.58%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Current Leases (2019 - 2020)

Updated

Vir Biotechnology (VIR) posted Current Leases of $300,000 for Q4 2020, up 26.6% from $237,000 a year earlier and unchanged from the prior quarter.

Analysis

Vir Biotechnology (VIR) Current Leases (2019 - 2020) Analysis & Trends

Since Q4 2019, Vir Biotechnology has reported Current Leases for 5 quarters.

  • In prior years, Vir Biotechnology's Current Leases was $237,000 in FY2019.
  • According to Business Quant data, Current Leases for the three prior quarters was $300,000 (Q3 2020), $244,000 (Q2 2020) and $240,000 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Vir Biotechnology 1.77 Bn -185.85 Mn 238.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 300,000.00
Sep 30, 2020 300,000.00
Jun 30, 2020 244,000.00
Mar 31, 2020 240,000.00
Dec 31, 2019 237,000.00
API Access

Vir Biotechnology Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=VIR&period=max&api_key=YOUR_API_KEY